Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Disease Progression × pembrolizumab × Clear all

Phase

Status

Unknown 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 23 Melanoma 16 Breast Neoplasms 9 Neoplasms 8 Triple Negative Breast Neoplasms 7 Head and Neck Neoplasms 7 Squamous Cell Carcinoma of Head and Neck 6 Ovarian Neoplasms 6 Lung Neoplasms 6 Carcinoma, Hepatocellular 6 Stomach Neoplasms 5 Pancreatic Neoplasms 5 Neoplasm Metastasis 5 Colorectal Neoplasms 5 Carcinoma, Renal Cell 5 Uterine Cervical Neoplasms 3 Prostatic Neoplasms 3 Lymphoma 3 Liver Neoplasms 3 Kidney Neoplasms 3 Hodgkin Disease 3 Glioblastoma 3 Esophageal Neoplasms 3 Carcinoma 3 Neoplasms, Squamous Cell 2 Gastrointestinal Neoplasms 2 Fallopian Tube Neoplasms 2 Esophageal Squamous Cell Carcinoma 2 Endometrial Neoplasms 2 Carcinoma, Transitional Cell 2

Interventions

pomalidomide 1 pembrolizumab 1 Temozolomide 1 Tamsulosin 1 Sodium Selenite 1 Radiomics 1 Hepatectomy 1 Epirubicin 1 Dexamethasone 1 Cyclophosphamide 1 Bevacizumab 1 10-propargyl-10-deazaaminopterin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03469804 2019-10-21

KAPKEY

Assistance Publique - Hôpitaux de Paris

Phase 2 Unknown

Sarcoma, Kaposi, Disease Progression

Data powered by HemOnc (CC BY 4.0) Colophon ⚡